About us
Contact
Study Office
Study Coordinating Group
Executive Board
Open Trials
Closed Trials
Publicized Trials
General
Study Planning
Study Implementation
Study Completion
Roadshow
Guidelines
Guidebook
Statements
Press Releases
Co-operation partners
National
International
other Links
The AGO Study Group is a non-profit organisation with the aim to enhance the therapy of pelvic tumours in women. It developed from the AGO Ovarian Cancer Study Group, which was founded in 1993.
Presentations
15th Annual Meeting 2007
- Regeln der AGO Studiengruppe
- Update der Studien im Follow up
- AGO-OVAR 11
- AGO-OVAR 11t- HISTO
- AGO-OVAR 10
- AGO-OVAR OP.3/LION
- AGO-OVAR 2.9/CALYPSO
- AGO-OVAR 2.12/HECTOR
- AGO-OVAR 2.11
- AGO GYN 6
- AGO-OVAR OP.2/DESKTOP II
- AGO GYN 5
- AGO GYN 7
- AGO Zervix 1
- HER2 neu
- Elderly Patients
- Immunologische Ansätze
- 15 Jahre AGO Studiengruppe - Rück- und Ausblick
- Primärtherapie
- Rezidivtherapie
German Version
|
Sitemap
|
Suche
|
Impressum
|
Kontakt
©
AGO Studiengruppe 2008